Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Oasmia Pharma Acquires Cancer Project KB9520 from Karo Pharma 10
Private Equity 11
Nexttobe Acquires Additional Stake In Oasmia Pharma From Alceco International 11
Partnerships 12
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 12
Oasmia Pharma Enters Into Co-Marketing Agreement With Pharmasyntez For Paclical 13
Oasmia Pharma Enters Into Co-Development Agreement With Pharmasyntez 14
Equity Offering 15
Oasmia Pharma Plans to Raise up to USD25 Million in Public Offering of Securities 15
Oasmia Pharma Raises USD18.8 Million in Rights Offering of Shares 16
Oasmia Pharma Raises USD7.8 Million in Private Placement of Shares 17
Oasmia Pharma Raises USD2.2 Million in Private Placement of Shares 18
Oasmia Pharma Completes Underwriters Partial Exercise of Over-Allotment Option of Public Offering for USD10.8 Million 19
Oasmia Pharma Raises USD23.8 Million in Rights Offering of Shares 21
Oasmia Pharma Raises USD7 Million in Private Placement of Shares 23
Oasmia Pharma Completes Private Placement Of Shares For US$11 Million 24
Oasmia Pharma Completes Rights Issue Of Shares For US$19 Million 25
Debt Offering 26
Oasmia Pharma Raises USD3.1 Million in Private Placement of 8% Convertible Instruments 26
Oasmia Pharma Raises USD3.3 Million in Private Placement of Convertible Instruments 27
Oasmia Pharmaceutical AB – Key Competitors 28
Oasmia Pharmaceutical AB – Key Employees 29
Oasmia Pharmaceutical AB – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Jun 08, 2018: Oasmia Pharmaceutical Year-end report for the financial year May 1, 2017 – April 30, 2018 31
Mar 02, 2018: Oasmia Pharmaceutical: Interim report for the period May 2017 – January 2018 36
Dec 01, 2017: Oasmia Pharmaceutical Interim report for the period May – October 2017 38
Sep 01, 2017: Oasmia Pharmaceutical: Interim report for the period May – July 2017 39
Jun 08, 2017: Oasmia Pharmaceutical: Year-end report for the financial year May 1, 2016 – April 30, 2017 41
Corporate Communications 43
Oct 04, 2017: Oasmia Pharmaceutical Announces Resignation of its Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oasmia Pharmaceutical AB, Deals By Therapy Area, 2012 to YTD 2018 8
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oasmia Pharma Acquires Cancer Project KB9520 from Karo Pharma 10
Nexttobe Acquires Additional Stake In Oasmia Pharma From Alceco International 11
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 12
Oasmia Pharma Enters Into Co-Marketing Agreement With Pharmasyntez For Paclical 13
Oasmia Pharma Enters Into Co-Development Agreement With Pharmasyntez 14
Oasmia Pharma Plans to Raise up to USD25 Million in Public Offering of Securities 15
Oasmia Pharma Raises USD18.8 Million in Rights Offering of Shares 16
Oasmia Pharma Raises USD7.8 Million in Private Placement of Shares 17
Oasmia Pharma Raises USD2.2 Million in Private Placement of Shares 18
Oasmia Pharma Completes Underwriters Partial Exercise of Over-Allotment Option of Public Offering for USD10.8 Million 19
Oasmia Pharma Raises USD23.8 Million in Rights Offering of Shares 21
Oasmia Pharma Raises USD7 Million in Private Placement of Shares 23
Oasmia Pharma Completes Private Placement Of Shares For US$11 Million 24
Oasmia Pharma Completes Rights Issue Of Shares For US$19 Million 25
Oasmia Pharma Raises USD3.1 Million in Private Placement of 8% Convertible Instruments 26
Oasmia Pharma Raises USD3.3 Million in Private Placement of Convertible Instruments 27
Oasmia Pharmaceutical AB, Key Competitors 28
Oasmia Pharmaceutical AB, Key Employees 29
Oasmia Pharmaceutical AB, Subsidiaries 30
List of Figures
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oasmia Pharmaceutical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8